Get a unique glimpse behind the scenes at MIMETAS and discover how groundbreaking research from Leiden is helping to develop better treatments worldwide.
This month, Leiden University Medical Centre (LUMC) is drawing particular attention to a topic that is becoming increasingly prominent on the global health agenda: women’s health.
LeydenJar has been awarded the prestigious Peter Wennink Tech Award 2026 in recognition of its breakthrough work in next-generation battery technology.
LUMC is pioneering an innovative approach with a new catheter-based treatment for pulmonary embolism, enabling patients to recover more quickly and reducing the risk of death.
For patients with advanced cancer, standard treatments may no longer be effective. Research by the LUMC suggests that off-label medicines may offer a potential alternative treatment.
Growing older naturally coincides with a gradual loss of muscle mass and strength. Researchers at the LUMC and the Universities of Granada and Almería discovered a gut bacterium that may aid in slowing, or even preventing, this process.